Ute Hoch Selected Research

Ute Hoch Research Topics

Disease

20	Neoplasms (Cancer) 10/2022 - 09/2008
10	Breast Neoplasms (Breast Cancer) 01/2022 - 06/2009
6	Melanoma (Melanoma, Malignant) 10/2021 - 06/2009
5	Brain Neoplasms (Brain Tumor) 01/2022 - 10/2015
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 01/2020
2	Disease Progression 01/2022 - 12/2017
2	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2015
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 12/2017
2	Neutropenia 12/2017 - 01/2017
2	Diarrhea 12/2017 - 01/2013
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2010 - 09/2009
2	Multiple Myeloma 06/2010 - 09/2009
2	Ovarian Neoplasms (Ovarian Cancer) 04/2010 - 03/2009
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2010 - 03/2009
1	Carcinoma (Carcinomatosis) 10/2022
1	Urologic Neoplasms (Urological Cancer) 10/2022
1	Syncope (Fainting) 01/2022
1	Miosis 01/2020
1	Dizziness (Lightheadedness) 01/2020
1	Fibrosarcoma 01/2020
1	Sleepiness 01/2020
1	Opioid-Related Disorders (Opiate Addiction) 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Circulating Neoplastic Cells 01/2018
1	Vomiting 12/2017
1	Abdominal Pain (Pain, Abdominal) 12/2017
1	Nausea 12/2017
1	Kidney Neoplasms (Kidney Cancer) 02/2016
1	Sepsis (Septicemia) 11/2015
1	Acute Kidney Injury (Acute Renal Failure) 11/2015
1	Pneumonia (Pneumonitis) 11/2015
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2015
1	Septic Shock (Toxic Shock Syndrome) 11/2015
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2013
1	Dry Eye Syndromes (Dry Eye Syndrome) 03/2012
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2011
1	Peritonitis 09/2010
1	Colonic Neoplasms (Colon Cancer) 03/2010
1	Lewis Lung Carcinoma 06/2009
1	Sarcoma (Soft Tissue Sarcoma) 06/2009
1	Hematologic Neoplasms (Hematological Malignancy) 06/2009

Drug/Important Bio-Agent (IBA)

13	etirinotecan pegolIBA 01/2022 - 01/2013
9	bempegaldesleukinIBA 10/2022 - 02/2016
6	Irinotecan (Camptosar)FDA LinkGeneric 01/2018 - 01/2013
5	Interleukin-2 (IL2)IBA 10/2021 - 02/2016
4	NivolumabIBA 10/2022 - 01/2020
4	AnthracyclinesIBA 09/2017 - 02/2011
4	taxaneIBA 09/2017 - 11/2013
4	vosaroxinIBA 02/2011 - 03/2009
3	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2018
3	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2019 - 02/2016
3	Capecitabine (Xeloda)FDA Link 09/2017 - 11/2015
3	Aurora KinasesIBA 03/2010 - 09/2008
2	CytokinesIBA 01/2019 - 02/2016
2	Topoisomerase I InhibitorsIBA 01/2018 - 12/2014
2	PolymersIBA 09/2017 - 12/2014
2	N- (5- (((5- (1,1- dimethylethyl)- 2- oxazolyl)methyl)thio)- 2- thiazolyl)- 4- piperidinecarboxamideIBA 06/2010 - 09/2009
2	SNS 314IBA 03/2010 - 09/2009
2	Caspase 3 (Caspase-3)IBA 03/2010 - 06/2009
1	Cisplatin (Platino)FDA LinkGeneric 10/2022
1	ProdrugsIBA 10/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Lipase (Acid Lipase)FDA Link 01/2022
1	InterferonsIBA 01/2020
1	NKTR-181IBA 01/2020
1	Oxycodone (Oxycontin)FDA LinkGeneric 01/2020
1	Opioid Analgesics (Opioids)IBA 01/2020
1	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2020
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2017
1	Gemcitabine FDA Link 09/2017
1	Vinorelbine (Navelbine)FDA LinkGeneric 09/2017
1	Docetaxel (Taxotere)FDA Link 09/2017
1	130-nm albumin-bound paclitaxelIBA 09/2017
1	eribulin FDA Link 09/2017
1	ixabepilone (BMS 247550)FDA Link 09/2017
1	CamptothecinIBA 01/2017
1	aldesleukin (Proleukin)FDA Link 02/2016
1	Cholinergic Agents (Cholinergics)IBA 01/2013
1	Ophthalmic Solutions (Eye Drops)IBA 03/2012
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 03/2012
1	1,2,3,4-tetrahydroisoquinolineIBA 03/2012
1	lifitegrastIBA 03/2012
1	Topoisomerase II InhibitorsIBA 02/2011
1	Etoposide (VP 16)FDA LinkGeneric 02/2011
1	EstersIBA 09/2010
1	QuinolonesIBA 04/2010
1	Histones (Histone)IBA 03/2010
1	2-aminobenzimidazoleIBA 09/2009
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 09/2009
1	Urea (Carbamide)FDA LinkGeneric 09/2009
1	CaspasesIBA 06/2009

Therapy/Procedure

7	Therapeutics 10/2022 - 02/2011
5	Drug Therapy (Chemotherapy) 10/2022 - 02/2011
4	Immunotherapy 01/2020 - 02/2016
1	Radiotherapy 01/2020
1	Aftercare (After-Treatment) 01/2018
1	Intravenous Infusions 11/2015
1	Oral Administration 09/2010
1	Intravenous Administration 09/2010